GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » Institutional Ownership

BetterLife Pharma (STU:NPAU) Institutional Ownership : 0.08% (As of Jun. 07, 2024)


View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BetterLife Pharma's institutional ownership is 0.08%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BetterLife Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BetterLife Pharma's Float Percentage Of Total Shares Outstanding is 73.40%.


BetterLife Pharma Institutional Ownership Historical Data

The historical data trend for BetterLife Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma Institutional Ownership Chart

BetterLife Pharma Historical Data

The historical data trend for BetterLife Pharma can be seen below:

2021-04-30 2021-05-31 2021-06-30 2021-07-31 2021-08-31 2021-09-30 2021-10-31 2021-11-30 2021-12-31 2022-01-31
Institutional Ownership 0.35 0.27 0.68 0.68 0.70 0.70 0.69 0.69 0.20 0.08

BetterLife Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


BetterLife Pharma (STU:NPAU) Business Description

Traded in Other Exchanges
Address
1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6
BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines